Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
scientific article
Author/s
author: Holger Eidtmann, Michael Untch, Evandro de Azambuja, Martine Piccart, Nadia Harbeck, Serena Di Cosimo, Henry Leonidas Gómez, Chiun-Sheng Huang, Antonio C. Wolff, Giuseppe Viale, Amylou Dueck, Aron Goldhirsch, Edith A. Perez, István Láng, José Baselga
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.